Rhumbline Advisers Singular Genomics Systems, Inc. Transaction History

Rhumbline Advisers

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.37 - $0.99 $1,963 - $5,252	-5,306 Reduced 76.15%	1,662 $0
Q2 2023 Aug 08, 2023	SELL	$0.78 - $1.28 $60,679 - $99,576	-77,794 Reduced 91.78%	6,968 $5,000
Q1 2023 May 11, 2023	BUY	$1.1 - $2.95 $2,079 - $5,575	1,890 Added 2.28%	84,762 $103,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $584 - $869	321 Added 0.39%	82,872 $167,000
Q3 2022 Nov 10, 2022	BUY	$2.5 - $4.73 $14,995 - $28,370	5,998 Added 7.84%	82,551 $206,000
Q2 2022 Aug 11, 2022	BUY	$2.86 - $6.44 $114,889 - $258,701	40,171 Added 110.41%	76,553 $292,000
Q1 2022 May 12, 2022	BUY	$5.94 - $12.09 $216,109 - $439,858	36,382 New	36,382 $230,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.